Activation of FFAR4 can enhance GLP-1 secretion and improve insulin resistance and chronic inflammation in obese mice (Xiong et al., 2010; Oh et al., 2014), and improve colonic permeability in inflammatory bowel diseases mice (Salaga et al., 2021). Here, FFAR4 is linked to Insulin resistance.